Abstract: Compositions of anti-influenza vaccine containing nucleic acids encoding influenza proteins NP, M1 and NS-1 and methods of inducing a protective immune response using these compositions. Also included is the enhancement of antigenic presentation or increasing immunogenicity of an influenza NP, M1 and/or NS-1 polypeptide by modifying the three dimensional structure of the polypeptide.
Type:
Application
Filed:
August 1, 2006
Publication date:
May 31, 2007
Applicant:
Cure Lab, Inc.
Inventors:
Alexander Shneider, Peter Ilyinskii, Galini Thoidis